Precision Optics (PEYE) Stock Price, News & Analysis

Company Overview

Precision Optics Corporation, Inc. is a medical technology company that designs and manufactures miniature optical and imaging systems for use in minimally invasive medical procedures. Its products are intended to help physicians visualize anatomy through small-access surgical instruments and endoscopic devices.

The company’s offerings include miniature rigid and flexible endoscopes, high-definition and three-dimensional imaging systems, optical assemblies, and related camera and illumination technologies. Precision Optics also develops customized optical solutions and components for original equipment manufacturers in the medical device industry, supporting applications such as surgery, diagnostics, and other specialized visualization procedures.

Precision Optics is headquartered in Gardner, Massachusetts, and primarily serves medical device manufacturers and healthcare markets through its product development and manufacturing operations. The company has historically focused on proprietary miniature optics and integrated imaging technologies, although specific information about its current leadership and geographic customer base is limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 113,500 shs
• Average Volume: 9,793 shs
• Market Capitalization: $32.98 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 9/29/2025
• Today: 10/14/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:PEYE
• Previous Symbol: NASDAQ:PEYE
• CIK: 867840
• Web: www.poci.com
• Phone: (978) 630-1800
• Fax: 978-630-1487
• Employees: 80
• Year Founded: 1982

Profitability

• EPS (Trailing Twelve Months): ($0.06)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$930 thousand
• Net Margins: -5.93%
• Pretax Margin: -5.91%
• Return on Equity: -12.10%
• Return on Assets: -6.41%

Debt

• Debt-to-Equity Ratio: 0.23
• Current Ratio: 1.42
• Quick Ratio: 0.76

Sales & Book Value

• Annual Sales: $15.68 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.53 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 16,915,000
• Free Float: 13,075,000
• Market Cap: $32.98 million
• Optionable: Not Optionable
• Beta: 0.41